Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
25.49
+0.93 (3.79%)
At close: Aug 19, 2026, 4:00 PM EDT
25.99
+0.50 (1.96%)
After-hours: Aug 19, 2026, 7:43 PM EDT
Adaptive Biotechnologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 169.87 | 70.5 | 47.92 | 65.06 | 90.03 | 139.07 |
Short-Term Investments | 174.38 | 156.49 | 174.37 | 281.34 | 408.17 | 214 |
Cash & Short-Term Investments | 344.26 | 226.98 | 222.29 | 346.4 | 498.2 | 353.06 |
Cash Growth | 73.98% | 2.11% | -35.83% | -30.47% | 41.11% | -48.70% |
Accounts Receivable | 49.51 | 50.37 | 41.73 | 37.97 | 40.06 | 17.41 |
Other Receivables | 1.8 | 1.5 | 1.3 | 1 | 0.8 | 1.4 |
Receivables | 51.31 | 51.87 | 43.03 | 38.97 | 40.86 | 18.81 |
Inventory | 10.5 | 9.82 | 8.44 | 14.45 | 14.45 | 19.26 |
Prepaid Expenses | 14.5 | 11.52 | 9.99 | 10.37 | 8.64 | 11.62 |
Total Current Assets | 420.56 | 300.19 | 283.75 | 410.19 | 562.15 | 402.75 |
Property, Plant & Equipment | 68.57 | 74.72 | 94.38 | 120.32 | 164.21 | 172.94 |
Long-Term Investments | 27.48 | 13.23 | 33.66 | - | - | 217.15 |
Goodwill | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 |
Other Intangible Assets | 0.88 | 1.73 | 3.43 | 5.13 | 6.83 | 8.53 |
Other Long-Term Assets | 4.21 | 3.9 | 5.18 | 6.52 | 4.46 | 3.01 |
Total Assets | 640.68 | 512.74 | 539.38 | 661.13 | 856.62 | 923.34 |
Accounts Payable | 5.24 | 6.47 | 7.27 | 7.72 | 8.08 | 3.31 |
Accrued Expenses | 20.39 | 22.72 | 20.67 | 20.39 | 24.1 | 22.2 |
Current Portion of Long-Term Debt | - | 4.64 | 0.87 | - | - | - |
Current Portion of Leases | 8.82 | 8.92 | 10.24 | 9.38 | 9.23 | 5.06 |
Current Income Taxes Payable | - | 0.54 | 0.18 | 0.06 | 0.19 | 0.39 |
Current Unearned Revenue | 53.26 | 45.19 | 55.69 | 48.63 | 64.12 | 80.46 |
Other Current Liabilities | - | 1.43 | 3.15 | 1.84 | 4.07 | 2.39 |
Total Current Liabilities | 87.71 | 89.92 | 98.05 | 88.02 | 109.79 | 113.81 |
Long-Term Debt | 334.88 | 126.57 | 132.41 | 130.66 | 125.36 | - |
Long-Term Leases | 66.8 | 70.23 | 79.15 | 89.39 | 98.77 | 106.69 |
Long-Term Unearned Revenue | 0.61 | 1.01 | 27.26 | 44.79 | 58.6 | 98.75 |
Other Long-Term Liabilities | 0.02 | 0.02 | 0.02 | - | - | - |
Total Liabilities | 490.02 | 287.74 | 336.89 | 352.86 | 392.52 | 319.24 |
Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 1,566 | 1,582 | 1,506 | 1,453 | 1,387 | 1,324 |
Retained Earnings | -1,423 | -1,363 | -1,304 | -1,144 | -919.08 | -718.89 |
Comprehensive Income & Other | -0.21 | 0.25 | 0.17 | 0.22 | -4.12 | -1.14 |
Total Common Equity | 142.91 | 218.79 | 202.71 | 308.4 | 464.17 | 603.99 |
Minority Interest | 7.75 | 6.21 | -0.22 | -0.12 | -0.07 | 0.11 |
Shareholders' Equity | 150.66 | 225 | 202.49 | 308.28 | 464.1 | 604.1 |
Total Liabilities & Equity | 640.68 | 512.74 | 539.38 | 661.13 | 856.62 | 923.34 |
Total Debt | 410.5 | 210.36 | 222.67 | 229.43 | 233.36 | 111.74 |
Net Cash (Debt) | -38.76 | 29.86 | 33.29 | 116.97 | 264.83 | 458.47 |
Net Cash Growth | - | -10.30% | -71.54% | -55.83% | -42.23% | -34.41% |
Net Cash Per Share | -0.25 | 0.20 | 0.23 | 0.81 | 1.86 | 3.27 |
Filing Date Shares Outstanding | 159.6 | 153.98 | 148.58 | 145.09 | 143.23 | 141.58 |
Total Common Shares Outstanding | 159.06 | 153.78 | 147.77 | 145.08 | 143.11 | 141.39 |
Working Capital | 332.85 | 210.27 | 185.7 | 322.17 | 452.36 | 288.94 |
Book Value Per Share | 0.90 | 1.42 | 1.37 | 2.13 | 3.24 | 4.27 |
Tangible Book Value | 23.06 | 98.1 | 80.31 | 184.3 | 338.37 | 476.49 |
Tangible Book Value Per Share | 0.14 | 0.64 | 0.54 | 1.27 | 2.36 | 3.37 |
Machinery | - | 54.39 | 59.33 | 61.36 | 56.7 | 48.88 |
Construction In Progress | - | 1.1 | 2.57 | 3.41 | 7.63 | 5.66 |
Leasehold Improvements | - | 73.11 | 73.28 | 74.73 | 72.4 | 65.96 |